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Background: Prealbumin, a sensitive marker for proteineenergy status, is also
known as an independent risk factor for mortality in hemodialysis patients. We
investigated the impact of prealbumin on survival in incident peritoneal dialysis
(PD) patients.
Methods: In total, 136 incident PD patients (mean age, 53.0 ± 15.8 years) between
2002 and 2007 were enrolled in the study. Laboratory data, dialysis adequacy, and
nutritional parameters were assessed 3 months after PD initiation. Patients were
classiﬁed into 2 groups according to prealbumin level: high prealbumin ( 40 mg/dL)
and low prealbumin (< 40 mg/dL).
Results: The patients in the low-prealbumin group were older and had more
comorbidities such as diabetes and cardiovascular diseases compared with the pa-
tients in the high-prealbumin group. Mean subjective global assessment scores
were lower, and the high-sensitivity C-reactive protein levels were higher in the
low-prealbumin group. Serum creatinine, albumin, and transferrin levels; percent
lean body mass; and normalized protein catabolic rate were positively associated,
whereas subjective global assessment scores and high-sensitivity C-reactive protein
levels were negatively associated with prealbumin concentration. During the me-
dian follow-up of 49 months, patients in the lower prealbumin group had a higher
mortality rate. Multivariate analysis revealed that prealbumin < 40 mg/dL (hazard
ratio, 2.30; 95% conﬁdence interval, 1.14e4.64) was an independent risk factor for
mortality. In receiver operating characteristic curves, the area under the curve of
prealbumin for mortality was the largest among the parameters.
Conclusion: Prealbumin levels were an independent and sensitive predictor for
mortality in incident PD patients, showing a good correlation with nutritional and
inﬂammatory markers.
Copyright © 2016. The Korean Society of Nephrology. Published by Elsevier. This is
an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).y, Department of Internal
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The National Kidney Foundation Kidney Disease Outcomes
Quality Initiative clinical practice guideline for nutrition in end-
stage renal disease (ESRD) has suggested that more careful
attention to the relationship between nutrition and dialysis
outcomes is needed [1,2]. The dialysis procedure itself results in
protein and nutrient losses into the dialysate and changes of
metabolism [3]. Moreover, inadequate dialysis leads to
anorexia, increased levels of leptin, and impaired taste acuity
[1,4]. As a result, 39% to more than 50% of maintenance dialysis
patients have proteineenergy malnutrition [5,6]. In this
context, prior studies have investigated the relationship be-
tween various nutritional markers and mortality in patients on
dialysis [5e8].
Prealbumin, also known as transthyretin, is a 54-kDa hepatic
secretory protein and functions primarily as a transport protein
for thyroxin and vitamin A [9]. Serum prealbumin levels decline
in response to inadequate protein intake and acute or chronic
inﬂammation [10]. However, prealbumin levels may increase in
renal failure, presumably because of impaired degradation by
the kidney, and thus may not correlate with changes in other
nutritional parameters [11]. Nonetheless, many studies have
suggested that the serum prealbumin concentration is inde-
pendently associated with mortality in hemodialysis patients,
even after adjustment for other nutritional parameters
including albumin [5,12,13]. Prealbumin is also known as a
more sensitive marker for proteineenergy malnutrition than
albumin because the half-life of 2e3 days for prealbumin is
shorter than the half-life of 20 days for albumin [7,9].
However, data on the role of prealbumin in peritoneal
dialysis (PD) are limited, and controversies regarding optimal
prealbumin levels still exist [8,12,14]. We investigated the
impact of prealbumin on survival in incident PD patients and
evaluated the relationships between prealbumin and other
nutritional markers.
Methods
Study population
We enrolled 136 consecutive patients who started PD and
had baseline laboratory data, dialysis adequacy, and nutritional
parameters between January 1, 2002, and November 30, 2007,
at Kyungpook National University Hospital. Exclusion criteria
for this study were as follows: patients with infection at
enrollment and patients who had changed dialysis modality,
undergone renal transplantation, or transferred to another
dialysis unit. The Institutional Review Board of Kyungpook
National University Hospital approved this study. All study
procedures adhered to the Declaration of Helsinki.
Dialysis prescription and data collection
PD patients were followed regularly, and PD prescriptions
were adjusted by the patient's weight, peritoneal equilibration
characteristics, and clinical condition. Dialysis adequacy was
assessed via dialysate/plasma creatinine (Cr), ultraﬁltration
volume, urine volume, residual renal function, and weekly Kt/V
urea.
Laboratory data, dialysis adequacy, and nutritional param-
eters were assessed within 3 months after PD initiation. Onenrollment, demographic and clinical data including age, sex,
and cause of ESRD, and systemic comorbidities, such as dia-
betes, hypertension, and cardiovascular diseases, were
assessed. Cardiovascular disease is deﬁned as follows: (1) cor-
onary artery disease and myocardial infarction; (2) congestive
heart failure; (3) cerebrovascular disease, stroke, atrial ﬁbril-
lation, or peripheral arterial disease; and (4) sudden cardiac
death. Venous blood samples were assessed at regular visits
within 3 months.
Nutritional markers were deﬁned as follows: serum Cr, al-
bumin, total cholesterol, and transferrin levels; subjective global
assessment (SGA) scores; percent lean body mass (%LBM); and
normalized protein catabolic rate (nPCR). Lean body mass was
estimated by Cr kinetics [15]. High-sensitivity C-reactive protein
(hs-CRP) was deﬁned as an inﬂammatory marker. Other labora-
tory data included hemoglobin, blood urea nitrogen (BUN), tri-
glycerides, glucose (fasting blood sugar), lipoprotein(a), and
ferritin. Based on SGA scores, patients were subdivided into 3
groups: normal (6e7), mildly to moderately malnourished
(3e5), and severely malnourished (1e2) groups.
For evaluation of serum prealbumin, the samples were
centrifuged 20 minutes after collection, and then the serum
was kept at e18C. Prealbumin was determined by turbidi-
metric immunoassay using the COBAS INTEGRA 800 automated
analyzer (Integra; Roche, Basel, Switzerland). Correlations be-
tween prealbumin and other nutritional and inﬂammatory
markers were also analyzed.
Statistical analysis
Patients were classiﬁed into 2 groups according to the pre-
albumin level based on the results of previous studies
[12,13,16]: high prealbumin ( 40 mg/dL) and low prealbumin
(< 40 mg/dL). For comparison between the 2 groups, contin-
uous variables were evaluated with the independent t test, and
categorical variables were evaluated with the Pearson chi-
square test. A comparison of survival curves between the 2
groups was conducted with the KaplaneMeier survival analysis
and log-rank test. To identify independent predictors of mor-
tality, the hazard ratio (HR) and 95% conﬁdence interval (CI) for
each variable were calculated using the multivariate Cox pro-
portional hazard model with the backward conditional
method. The correlation between prealbumin and other
nutritional parameters and inﬂammation was analyzed with
the Pearson correlation coefﬁcient. Receiver operating charac-
teristic (ROC) curves were built, and the area under the ROC
curve (AUC) was calculated to evaluate the ability of each
nutritional parameter to predict mortality. The pairwise com-
parison of AUC values was performed using a method proposed
by DeLong et al [17] and MedCalc software, version 15.6.1
(MedCalc Software bvba, Ostend, Belgium). Statistical analyses
were performed with SPSS for Windows, version 18.0 (SPSS
Inc., Chicago, IL, USA). Values are shown as themean ± standard
deviation with a range, and a P value < 0.05 was considered
statistically signiﬁcant.
Results
Patient characteristics
The mean age of the enrolled patients was 53.0 ± 15.8 years,
and the number of men was 85 (62.5%). The causes of ESRD
Table 2. Comparisons of parameters between the 2 groups according
to the prealbumin level
Variables Prealbumin
 40 (n ¼ 56)
Prealbumin
< 40 (n ¼ 80)
P
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hypertension (11.0%), polycystic kidney disease (2.9%), and
others (2.2%). Patient demographic and clinical characteristics
are described in Table 1.Age (y) 46.0 ± 15.2 57.9 ± 14.4 < 0.001
Sex (male) 34 (60.7) 51 (63.8) 0.719
Primary renal disease 0.004
Diabetes 17 (30.4) 47 (58.8)
Hypertension 5 (8.9) 10 (12.5)
Glomerulonephritis 31 (55.4) 19 (23.8)
Polycystic kidney disease 2 (3.6) 2 (2.5)
Other 1 (1.8) 2 (2.5)
Cardiovascular diseases 11 (19.6) 34 (44.2) 0.003
D/P Cr 0.740
High 8 (14.3) 15 (18.8)
High average 29 (51.8) 39 (48.8)
Low average 18 (32.1) 23 (28.8)
Low 1 (1.8) 3 (3.8)
BMI (kg/m2) 21.7 ± 3.3 21.9 ± 2.7 0.668
SGA score 0.007
Normal 44 (78.6) 43 (53.8)
Mildly to moderately
malnourished
11 (19.6) 35 (43.7)
Severely malnourished 1 (1.8) 2 (2.5)
Prealbumin (mg/dL) 48.0 ± 6.8 30.3 ± 6.1 < 0.001Comparisons of parameters between high- and low-
prealbumin groups
Table 2 summarizes the clinical characteristics of the sub-
group analysis according to the prealbumin level. Among 136
total patients, 56 and 80 patients were divided into high- and
low-prealbumin groups, respectively. The low-prealbumin
group showed a greater number of patients with old age, dia-
betes, cardiovascular disease, low SGA scores, and hs-CRP
 1 mg/dL compared with the high-prealbumin group. Pa-
tients with low prealbumin were also associated with worse
nutritional markers, such as BUN, Cr, albumin, transferrin, %
LBM, and nPCR. However, there were no signiﬁcant differences
in hemoglobin, serum total protein, total cholesterol, triglyc-
eride, and ferritin levels between the groups.UF volume (mL/d) 806 ± 704 629 ± 679 0.029
Urine volume (mL/d) 697 ± 591 864 ± 694 0.147
RRF (mL/min) 2.8 ± 2.1 3.8 ± 3.0 0.039
Weekly Kt/V urea 2.3 ± 0.6 2.4 ± 0.7 0.165
Hemoglobin (g/dL) 10.7 ± 1.6 10.5 ± 1.6 0.517
hs-CRP (mg/L) 3.2 ± 5.1 10.1 ± 20.5 0.006
BUN (mg/dL) 48.7 ± 16.8 41.0 ± 16.8 0.010
Creatinine (mg/dL) 9.0 ± 3.7 7.0 ± 3.9 0.003
Protein (g/dL) 6.6 ± 0.7 6.6 ± 0.7 0.511
Albumin (g/dL) 3.7 ± 0.3 3.4 ± 0.4 < 0.001
Total cholesterol (mg/dL) 184.5 ± 41.0 179.7 ± 41.5 0.503
Triglycerides (mg/dL) 128.3 ± 83.8 117.1 ± 53.7 0.389
Glucose (mg/dL) 148.1 ± 66.2 218.2 ± 110.9 < 0.001
Lipoprotein(a) (mg/dL) 70.3 ± 49.1 81.5 ± 48.2 0.260
Transferrin (mg/dL) 197.7 ± 49.7 175.7 ± 38.5 0.005
Ferritin (mg/L) 192.2 ± 176.9 229.5 ± 176.4 0.256
%LBM 69.0 ± 10.8 60.1 ± 11.5 < 0.001
nPCR (g/kg/d) 1.0 ± 0.3 0.9 ± 0.2 0.010
Data are presented as n (%) or mean ± SD.
BMI, body mass index; BUN, blood urea nitrogen; D/P Cr, dialysate/
plasma creatinine; hs-CRP, high-sensitivity C-reactive protein; %LBM,
percent lean body mass; nPCR, normalized protein catabolic rate; RRF,
residual renal function; SGA, subjective global assessment; UF,
ultraﬁltration.
Table 1. Baseline demographics of peritoneal dialysis patients
(n ¼ 136)
Variables Value
Age (y) 53.0 ± 15.8
Sex (male) 85 (62.5)
Primary renal disease
Diabetes 64 (47.1)
Hypertension 15 (11.0)
Glomerulonephritis 51 (36.8)
Polycystic kidney disease 4 (2.9)
Other 3 (2.2)
Cardiovascular diseases 45 (33.1)
D/P Cr
High 23 (16.9)
High average 68 (50.0)
Low average 41 (30.1)
Low 4 (2.9)
SGA score
Normal (6e7) 87 (64.0)
Mildly to moderately malnourished (3e5) 46 (33.8)
Severely malnourished (1e2) 3 (2.2)
BMI (kg/m2) 21.9 ± 3.0
UF volume (mL/d) 702 ± 692
Urine volume (mL/d) 738 ± 618
RRF (mL/min) 3.3 ± 2.7
Weekly Kt/V urea 2.4 ± 0.6
Hemoglobin (g/dL) 10.6 ± 1.6
hs-CRP (mg/L) 7.2 ± 16.3
BUN (mg/dL) 44.1 ± 17.1
Creatinine (mg/dL) 7.8 ± 3.9
Protein (g/dL) 6.6 ± 0.7
Albumin (g/dL) 3.5 ± 0.4
Prealbumin (mg/dL) 37.6. ± 10.8
Total cholesterol (mg/dL) 181.7 ± 41.2
Triglycerides (mg/dL) 121.4 ± 66.8
Glucose (mg/dL) 189.6 ± 101.0
Lipoprotein(a) (mg/dL) 76.8 ± 48.7
Transferrin (mg/dL) 184.9 ± 44.7
Ferritin (me/L) 214.0 ± 176.8
%LBM 63.8 ± 12.0
nPCR (g/kg/d) 0.9 ± 0.3
Data are presented as n (%) or mean ± SD.
BMI, body mass index; BUN, blood urea nitrogen; D/P Cr, dialysate/
plasma creatinine; hs-CRP, high-sensitivity C-reactive protein; %LBM,
percent lean body mass; nPCR, normalized protein catabolic rate; RRF,
residual renal function; SD, standard deviation; SGA, subjective global
assessment; UF, ultraﬁltration.Correlations of prealbumin with other biochemical markers
Table 3 shows the correlations of prealbumin with age and
other biochemical markers in PD patients. Serum BUN, Cr, al-
bumin, and transferrin levels; %LBM; and nPCR were positively
associated with prealbumin concentration, whereas serum
glucose and hs-CRP levels and SGA score were negatively
associated with prealbumin concentration. Pearson correlation
analysis demonstrated negative correlation between pre-
albumin and residual renal function (R ¼ e0.244, P ¼ 0.004).
However, total cholesterol did not show a signiﬁcant correla-
tion with prealbumin.Prealbumin and patient survival
During the study period, 54 of 136 PD patients died. The
causes of mortality were as follows: cardiac disease (32%),
sepsis except peritonitis (28%), cerebrovascular accident (13%),
peritonitis (8%), malignancy (2%), and others (17%).
Table 3. Correlations of prealbumin with biochemical proﬁles in
peritoneal dialysis
Variables Correlation coefﬁcient P*
Serum creatinine (mg/dL) 0.336 < 0.001
Serum albumin (g/dL) 0.417 < 0.001
Total cholesterol (mg/dL) 0.103 0.236
Transferrin (mg/dL) 0.243 0.005
SGA score e0.292 0.001
%LBM 0.368 < 0.001
nPCR (g/kg/d) 0.202 0.018
hs-CRP (mg/L) e0.328 < 0.001
* P values were calculated by Pearson bivariate correlation analysis.
hs-CRP, high-sensitivity C-reactive protein; %LBM, percent lean body
mass; nPCR, normalized protein catabolic rate; SGA, subjective global
assessment.
Figure 1. KaplaneMeier survival analysis by the prealbumin level in 136
peritoneal dialysis patients. KaplaneMeier survival analysis demon-
strated that cumulative probability of 10-year survival in the high-pre-
albumin group was signiﬁcantly higher than that in the low-prealbumin
group (P < 0.001, Mantel log-rank test).
Table 4. Predictors of mortality in peritoneal dialysis patients: univariat
Variables Univariate Cox regression analys
Hazard ratio 95% CI
Age ( 65 y) 3.08 1.04e1.09
Diabetes 4.15 2.27e7.59
CVD 3.75 2.13e6.61
SGA score
Normal 1
Mild to moderate 2.56 1.46e4.48
Severe 13.29 3.77e46.84
Serum creatinine (mg/dL) 0.96 0.88e1.05
Total cholesterol (mg/dL) 1.00 0.99e1.00
Albumin (g/dL) 0.63 0.32e1.24
Prealbumin (< 40 mg/dL) 3.42 1.72e6.81
%LBM 0.97 0.95e0.99
UF volume 1.00 1.00e1.00
RRF (mL/min) 0.99 0.89e1.09
hs-CRP  1 mg/dL 1.92 1.05e3.51
Transferrin (mg/dL) 1.00 0.99e1.00
nPCR (g/kg/d) 1.63 0.63e4.20
* P values were calculated by multivariate Cox proportional regression anal
CI, conﬁdence interval; CVD, cardiovascular disease; hs-CRP, high-sensitivit
protein catabolic rate; RRF, residual renal function; SGA, subjective global as
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prealbumin groups during the mean follow-up of 50.5 ± 31.7
months. Patient survival in the low- and high-prealbumin
groups was 64.8% and 87.3% at 3 years, 50.7% and 79.8% at
5 years, and 29.8% and 75.6% at 10 years, respectively.
KaplaneMeier survival analysis demonstrated that 10-year
mortality in the low-prealbumin group was signiﬁcantly higher
than that in the high-prealbumin group (P < 0.001) (Fig. 1).
Table 4 demonstrates the Cox proportional hazards analysis
for independent predictors of mortality in PD patients. Uni-
variate analysis showed that older age (65 years and older),
diabetes, cardiovascular disease, low SGA scores, prealbumin
< 40 m/dL, lower %LBM, and hs-CRP 1 mg/dL were associated
with mortality. However, the serum albumin level did not in-
ﬂuence mortality in this regression model (P ¼ 0.184). Multi-
variate analysis revealed that prealbumin < 40 m/dL (HR, 2.30;
95% CI, 1.14e4.64), diabetes (HR, 4.02; 95% CI, 2.10e7.71), car-
diovascular disease (HR, 3.43; 95% CI, 1.88e6.24), and CRP
 1 mg/dL (HR, 2.11; 95% CI, 1.12e3.97) were independent risk
factors for mortality. To test the interaction between pre-
albumin and hs-CRP, the authors added an interaction term
(prealbumin  hs-CRP) to a regression model. As a result, there
was no statistical signiﬁcant interaction (P ¼ 0.192). Therefore,
we thought that our multivariate Cox proportional hazard
assumption is satisﬁed and the interaction term could be
dropped from the model. In addition to treating prealbumin as
a categorical variable, multivariate Cox regression analysis
demonstrated that HR of prealbumin level (as continuous var-
iable) for mortality was 0.962 (95% CI, 0.934e0.990).Comparison with other biochemical markers
Fig. 2 compares the AUC values of each nutritional param-
eter for mortality. The AUC values of prealbumin (0.705), hs-
CRP (0.651), %LBM (0.644), and Cr (0.603) were larger than
0.5 signiﬁcantly, which represents the chance of discrimina-
tion. Moreover, the pairwise comparison among ROC curves
showed that prealbumin had a larger AUC value compared with
that of classic nutritional parameters including albumine and multivariate Cox regression analysis
is Multivariate Cox regression analysis*
P Hazard ratio 95% CI P
< 0.001 e e
< 0.001 4.02 2.10e7.71 < 0.001
< 0.001 3.43 1.88e6.24 < 0.001
< 0.001 e e
0.001
< 0.001
0.329 e e e
0.163 e e e
0.184 e e e
< 0.001 2.30 1.14e4.64 0.020
0.008 e e e
0.245 e e e
0.777 e e e
0.034 2.11 1.12e3.97 0.021
0.504 e e e
0.314 e e e
ysis using the backward conditional method.
y C-reactive protein; %LBM, percent lean body mass; nPCR, normalized
sessment; UF, ultraﬁltration.
Figure 2. Comparison of AUC values among various nutritional pa-
rameters for survival in peritoneal dialysis patients. The AUC values of
prealbumin (0.705), hs-CRP (0.651), %LBM (0.644), and Cr (0.603) were
statistically signiﬁcantly larger than 0.5, which represents the chance of
discrimination. Moreover, the AUC value of prealbumin for mortality was
the largest among the parameters.
AUC, area under the receiver operating characteristic curve; Cr, creatinine;
hs-CRP, high-sensitivity C-reactive protein; %LBM, percent lean body mass;
nPCR, normalized protein catabolic rate; T-cholesterol, total cholesterol.
Lee et al / Low prealbumin as a predictor of mortality in PD 173(P¼ 0.013), total cholesterol (P¼ 0.037), transferrin (P¼ 0.011),
and nPCR (P ¼ 0.028). Although the AUC value of prealbumin
also was larger than that of hs-CRP, %LBM, and Cr, there was no
statistical signiﬁcance (P ¼ 0.287, 0.243, and 0.076, respec-
tively). However, hs-CRP, %LBM, and Cr showed no statistically
signiﬁcant difference in AUC compared with other nutritional
parameters (all P values > 0.05; Table 5).
Discussion
We investigated the impact of prealbumin on survival and
compared its predictability for mortality with other nutritional
or inﬂammatory markers in incident PD patients. The patients
in the low-prealbumin group were older and had more
comorbidities such as diabetes and cardiovascular diseases
compared with the patients in the high-prealbumin group. InTable 5. Comparison of AUC among various nutritional parameters
for survival in peritoneal dialysis patients
Variables AUC 95% CI P* Py
Prealbumin 0.705 0.611e0.799 < 0.001 e
hs-CRP 0.651 0.551e0.750 0.004 0.287
%LBM 0.644 0.545e0.742 0.006 0.243
Cr 0.603 0.502e0.705 0.050 0.076
Albumin 0.579 0.480e0.678 0.133 0.010
Total cholesterol 0.572 0.470e0.674 0.172 0.031
Transferrin 0.545 0.440e0.651 0.390 0.013
nPCR 0.455 0.354e0.557 0.398 0.012
* The pairwise comparison of AUC values between parameters and 0.5
(chance of discrimination).
y The pairwise comparison of AUC values between parameters and
prealbumin.
AUC, area under the receiver operating characteristic curve; CI, conﬁ-
dence interval; Cr, creatinine; hs-CRP, high-sensitive C-reactive protein;
%LBM, percent lean body mass; nPCR, normalized protein catabolic rate.addition, SGA scores were lower but CRP levels were higher in
the low-prealbumin group. Even after adjustment for de-
mographic, clinical, and biochemical factors, low prealbumin
was an independent risk factor for mortality. Moreover, the
AUC value of prealbumin for mortality was the largest among
the various nutritional parameters, whereas classic nutritional
markers such as albumin, cholesterol, BUN, and Cr did not show
statistical signiﬁcance in our results. Our results conﬁrmed the
clinical importance of prealbumin in the survival of PD patients.
Several studies have suggested the use of serum prealbumin
as a better surrogate of nutritional status and cardiovascular
outcome and a predictor of mortality in patients with mainte-
nance HD [5,7,16,18]. The cumulative survival of HD patients
with prealbumin > 30 mg/dL was signiﬁcantly better than that
of patients with prealbumin < 30 mg/dL [12,14]. In a North
American cohort study with maintenance HD, patients with
prealbumin > 40 mg/dL showed better survival rates compared
with patients with lower prealbumin [13]. Higher prealbumin
was also associated with greater survival even among different
races including African American, Hispanic white, and non-
Hispanic white [19].
However, there are few studies on the association between
prealbumin and mortality in PD patients. Previous studies
[8,12,14] reported that prealbumin < 30 mg/dL was associated
with an increased mortality rate compared with higher pre-
albumin values. Similarly, Avram et al [7] reported that serum
prealbumin was an independent predictor of mortality in PD
patients over 12 years. In our study, we set prealbumin
< 40 mg/dL as the reference value to predict mortality.
KaplaneMeier survival analysis also demonstrated that mor-
tality in the low-prealbumin group was signiﬁcantly higher
than that in the high-prealbumin group over 10 years. Our re-
sults conﬁrmed those of previous studies [12,14], which sug-
gested that the cumulative survival of the high-prealbumin
group was better than that of the low-prealbumin group of PD
patients.
There are controversies on optimal prealbumin levels for
mortality prediction in dialysis patients. We deﬁned the low-
prealbumin group as prealbumin < 40 mg/dL, which is slightly
higher than the criteria (prealbumin < 30 mg/dL) for the clin-
ical diagnosis of proteineenergy wasting syndrome in chronic
kidney disease suggested by the International Society of Renal
Nutrition and Metabolism Expert Panel and other clinic-based
studies [12,14,20,21]. On the contrary, 1 nutritional study on
dialysis patients suggested that the ideal level of prealbumin
required to maintain an adequate nutritional status of PD pa-
tients may be higher than that of HD patients [12]. A US study
with 959 dialysis patients reported that the mean prealbumin
level of PD patients (35 mg/dL) was higher than that of HD
patients (26.5 mg/dL) [7], which was also conﬁrmed in the
results of Sreedhara et al [14]. Moreover, Mittman et al [12]
reported that the predictive power of prealbumin for mortal-
ity in PD patients appears to differ from that in HD patients, and
low prealbumin (< 30 mg/dL) was not a signiﬁcant risk factor
for mortality in PD patients by multivariate regression analysis.
In this context, we deﬁned the low-prealbumin group as pre-
albumin < 40 mg/dL as some researchers have set the serum
prealbumin level of 40 mg/dL as the reference value [13,16].
These researchers reported that low prealbumin concentra-
tions were associated with mortality and hospitalization in-
dependent of serum albumin and other clinical characteristics,
which was in accordance with our results.
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changes in circulating prealbumin concentrations [22]. Thus,
many studies regarding malnutrition and inﬂammation in PD
patients reported that prealbumin continued to correlate with
other nutritional markers after adjusting for age, race, sex, dia-
betes, and CRP level [23e25]. Pearson correlation analysis
demonstrated negative correlation (R ¼ e0.244, P ¼ 0.004) be-
tween prealbumin and residual renal function in our results.
Prealbumin is excreted by the kidney via glomerular ﬁltration
[26]. Moreover, in previous studies [26e27], recommendations
for the routine use of serum prealbumin levels as a marker are
temperedby the fact thatprealbumin levels are increased in renal
failure, presumably due to impaired degradation by the kidney
[11]. These mechanisms may affect this negative correlation be-
tween prealbumin and residual renal function in our results.
Our study also demonstrated that prealbumin correlated
with other nutritional markers, including serum Cr, glucose,
and transferrin levels; %LBM; nPCR; SGA score; and hs-CRP
level. In addition, because the half-life of prealbumin is
shorter than that of albumin, previous studies suggested that
prealbumin may be a more sensitive nutritional marker than
either serum albumin or transferrin [5,12,14,20,28]. In our
study, the AUC value of prealbumin for mortality was the
largest among the various nutritional parameters, whereas
serum albumin did not reach a clinically signiﬁcant relationship
with mortality by AUC and multivariate analyses.
On the contrary, Avram et al [7] reported that serum albu-
min is an independent predictor of mortality in patients on PD
(relative risk, 0.52) in the univariate regression model, and
higher enrollment level of serum albumin is associated with
better survival [29]. Moreover, a low serum albumin level had
been used as an indicator of malnutrition in dialysis patients
[30]. However, in these studies, multivariate Cox regression
analyses demonstrated that the level of serum albumin is not a
risk factor of mortality [7,29]. Similarly, previous studies sug-
gested that prealbumin is the best nutritional predictor of
survival in HD and PD patients, whereas the serum albumin is
not a predictor for death in multivariate Cox regression analysis
[12,14]. These results were consistent with our ﬁndings. Thus,
we could conclude that monitoring of serum prealbumin levels
is a useful tool for predicting mortality compared with other
conventional markers.
There are some limitations in our study. First, the study
design was observational; thus, we could not conﬁrm a cause-
and-effect relationship in the association of prealbumin and
other markers [31]. In addition, we could not analyze the
relationship between the prealbumin level and changes in
nutritional parameters because of retrospective design and
irregular follow-up sampling. Second, we could not entirely
exclude the uncounted confounding variables although we
tried to exclude the potential confounding factors. In addition,
the potential conditions affecting prealbumin levels, such as
hepatic diseases, protein-losing enteropathy, or zinc deﬁciency,
were not completely excluded, and important potential risk
factors were not adjusted: blood pressure, glycemic control,
anemia, mineral bone disorder, and some medications that can
inﬂuence mortality (angiotensin II receptor blocker, statin, etc).
Nevertheless, this study has the strength of having a relatively
long-term follow-up duration of 50.5 months. Furthermore,
this study was the ﬁrst to compare AUC values of prealbumin
with various nutritional and inﬂammatory markers that could
predict mortality.In conclusion, prealbumin measurement was a useful tool to
assess the nutritional and inﬂammatory states of PD patients
and also was the best predictor of mortality for PD patients
among all tested nutritional parameters in this study.
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